Log in

Adaptimmune Therapeutics Price Target, Predictions & Analyst Ratings

-0.38 (-7.95 %)
(As of 10/28/2020 12:00 AM ET)
Today's Range
Now: $4.40
50-Day Range
MA: $7.75
52-Week Range
Now: $4.40
Volume1.69 million shs
Average Volume1.91 million shs
Market Capitalization$572.48 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Adaptimmune Therapeutics (NASDAQ:ADAP) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
6 Wall Street analysts have issued ratings and price targets for Adaptimmune Therapeutics in the last 12 months. Their average twelve-month price target is $16.50, predicting that the stock has a possible upside of 275.00%. The high price target for ADAP is $42.00 and the low price target for ADAP is $5.00. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
ADAP Consensus Rating: BuyBuyHoldBuy
ADAP Consensus Rating Score: 2.502.502.402.57
ADAP Analyst Ratings: 0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
ADAP Consensus Price Target: $16.50$16.50$7.00$5.03
ADAP Price Target Upside: 275.00% upside114.56% upside3.58% downside31.54% upside

Adaptimmune Therapeutics (NASDAQ:ADAP) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Adaptimmune Therapeutics (NASDAQ:ADAP) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/9/2020Morgan StanleyInitiated CoverageEqual Weight$42.00 ➝ $42.00Low
8/12/2020Piper SandlerInitiated CoverageOverweightMedium
8/6/2020SVB LeerinkLower Price TargetMarket Perform$11.00 ➝ $10.00High
6/1/2020MizuhoBoost Price TargetNeutral$3.00 ➝ $9.00High
4/27/2020CitigroupLower Price TargetBuy$8.00 ➝ $5.00High
11/7/2019CowenReiterated RatingBuyLow
8/1/2019GuggenheimDowngradeBuy ➝ NeutralHigh
5/31/2019Roth CapitalInitiated CoverageBuy$7.00Medium
5/7/2019Raymond JamesLower Price TargetOutperform$16.00 ➝ $6.00Low
12/13/2018SunTrust BanksLower Price TargetBuy$12.00Medium
(Data available from 10/29/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.